HMG-CoA reductase inhibitor simvastatin overcomes bortezomib-induced apoptosis resistance by disrupting a geranylgeranyl pyrophosphate-dependent survival pathway. | Biochem Biophys Res Commun;374(2): 309-14, 2008 Sep 19. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

HMG-CoA reductase inhibitor simvastatin overcomes bortezomib-induced apoptosis resistance by disrupting a geranylgeranyl pyrophosphate-dependent survival pathway.

Fuchs, Dominik; Berges, Carsten; Opelz, Gerhard; Daniel, Volker; Naujokat, Cord.

Affiliation

Fuchs D; Department of Transplantation Immunology, Institute of Immunology, University of Heidelberg, Im Neuenheimer Feld 305, D-69120 Heidelberg, Germany.

Biochem Biophys Res Commun ; 374(2): 309-14, 2008 Sep 19.

Article in En | MEDLINE | ID: mdl-18625202

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polyisoprenyl Phosphates / Burkitt Lymphoma / Apoptosis / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Simvastatin Limits: Humans Language: En Journal: Biochem Biophys Res Commun Year: 2008 Document type: Article Affiliation country:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polyisoprenyl Phosphates / Burkitt Lymphoma / Apoptosis / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Simvastatin Limits: Humans Language: En Journal: Biochem Biophys Res Commun Year: 2008 Document type: Article Affiliation country: